This compound is a boronic ester derivative featuring a pyridine ring and a dioxaborolane group. It serves as a pharmaceutical intermediate for active pharmaceutical ingredient (API) synthesis, commonly used in medicinal chemistry and drug manufacturing.
Portée du contenu: Les informations de cette page concernent l'identification chimique ainsi que les contextes d'approvisionnement industriel, de recherche et de production. Elles ne constituent ni une allégation thérapeutique, ni un avis médical, ni une notice d'utilisation médicamenteuse.
Approvisionnement ou fourniture de ce composé?
Publiez votre inventaire ou une demande d'achat
CAS 1009033-87-7
4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine
Research reagent for synthesis
Tert-butyl (3S,4S)-3-amino-4-fluoropyrrolidine-1-carboxylate
Pharmaceutical intermediate for drug synthesis
Tert-butyl (3R,4S)-3-amino-4-fluoropyrrolidine-1-carboxylate
Pharmaceutical intermediate for drug synthesis
2-((2S)-Pyrrolidin-2-yl)-5-(4-(4-(2-((2S)-pyrrolidin-2-yl)-1H-imidazol-5-yl)phenyl)phenyl)-1himidazole tetrahydrochloride
pharmaceutical intermediate
(S)-2-((1R,3aR,4S,7aR)-4-((tert-butyldimethylsilyl)oxy)-7a-methyloctahydro-1H-inden-1-yl)propan-1-ol
pharmaceutical intermediate
4-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]pyridine
PTNMCYWJKRZCDE-UHFFFAOYSA-N
B1(OC(C(O1)(C)C)(C)C)C2=CC=C(C=C2)C3=CC=NC=C3
—